William Ince

7PUBLICATIONS
33CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.

|May 07, 2026
Precision Immunotherapy: Revolutionizing Cancer Treatment With Targeted Innovations.

|Nov 20, 2024
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.

Ricky Frazer, José Ángel Arranz, Sergio Vázquez Estévez

|Jun 18, 2024
Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives.

Elinor R Gatfield, John Tadross, William Ince

|Dec 07, 2021
Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?

Will Ince, Tim Eisen

Pageof 2

Frequent Collaborators

2 joint publications

Omi Parikh

2 joint publications

Naveen S Vasudev

1 joint publications

Kate Fife

1 joint publications

Bernadett Szabados